Mitochondrial DNA deletions/rearrangements in Parkinson disease and related neurodegenerative disorders

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 7, 2002, Pages 634-639

  Gu, Guangyu ^a   Reyes, Patricio F ^a   Golden, Gregory T ^a   Woltjer, Randall L ^a   Hulette, Christine ^a   Montine, Thomas J ^a   Zhang, Jing ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Energy metabolism; Free radicals; Mitochondria; Oxidative stress; Parkinsonism

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENERGY METABOLISM; GENE DELETION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0036298182     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.7.634     Document Type: Article

References (48)

1. Disorders of movement and system degeneration
2. Free radicals and mitochondrial dysfunction in Parkinson's disease
3. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
4. Mitochondrial DNA and Parkinson's disease
5. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes
6. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease
7. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family
8. Point mutations of mitochondrial genome in Parkinson's disease
9. Origin and functional consequences of the complex I defect in Parkinson's disease
10. Genetic and environmental risk factors in Parkinson's disease
11. The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality
12. Epidemiology versus genetics in Parkinson's disease: Progress in resolving an age-old debate
13. Mitochondrial genetics: A paradigm for aging and degenerative diseases?
14. Replication of animal mitochondrial DNA
15. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases
16. Diseases of the mitochondrial DNA
17. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues
18. Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age
19. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains
20. Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human ageing
21. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
22. The mitochondrial common deletion in Parkinson's disease and related movement disorders
23. Complete mitochondrial genome amplification
24. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle
25. Efficient and specific amplification of identified partial duplications of human mitochondrial DNA by long PCR
26. Deltoid human muscle mtDNA is extensively rearranged in old age subjects
27. Detection of a specific mitochondrial DNA deletion in tissues of older humans
28. Mitochondrial DNA rearrangements in aging human brain and in situ PCR of mtDNA
29. Sequence and organization of the human mitochondrial genome
30. Oxidative mechanisms in nigral cell death in Parkinson's disease
31. The free radical theory of aging matures
32. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons
33. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
34. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
35. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
36. MPP(+)-induced neurotoxicity in mouse is age-dependent: Evidenced by the selective inhibition of complexes of electron transport
37. Mechanisms of MPTP toxicity
38. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation
39. Mitochondrial dysfunction in Parkinson's disease
40. The pathobiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence
41. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro
42. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
43. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections
44. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1): A putative nigral endotoxin of relevance to Parkinson's disease
45. Fibroblasts that express aromatic amino acid decarboxylase have increased sensitivity to the synergistic cytotoxicity of L-dopa and manganese
46. Neurotoxicity of endogenous cysteinylcatechols
47. Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures
48. Differential expression of AMPA receptor subunits in dopamine neurons of the rat brain: A double immunocytochemical study